View Item 

Show simple item record

Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations
dc.contributor.authorIzzy, Manhal
dc.contributor.authorFortune, Brett E.
dc.contributor.authorSerper, Marina
dc.contributor.authorBhave, Nicole
dc.contributor.authordeLemos, Andrew
dc.contributor.authorGallegos-Orozco, Juan F.
dc.contributor.authorGuerrero-Miranda, Cesar
dc.contributor.authorHall, Shelley
dc.contributor.authorHarinstein, Matthew E.
dc.contributor.authorKaras, Maria G.
dc.contributor.authorKriss, Michael
dc.contributor.authorLim, Nicholas
dc.contributor.authorPalardy, Maryse
dc.contributor.authorSawinski, Deirdre
dc.contributor.authorSchonfeld, Emily
dc.contributor.authorSeetharam, Anil
dc.contributor.authorSharma, Pratima
dc.contributor.authorTallaj, Jose
dc.contributor.authorDadhania, Darshana M.
dc.contributor.authorVanWagner, Lisa B.
dc.date.accessioned2023-01-11T16:28:09Z
dc.date.available2024-01-11 11:28:07en
dc.date.available2023-01-11T16:28:09Z
dc.date.issued2022-12
dc.identifier.citationIzzy, Manhal; Fortune, Brett E.; Serper, Marina; Bhave, Nicole; deLemos, Andrew; Gallegos-Orozco, Juan F. ; Guerrero-Miranda, Cesar ; Hall, Shelley; Harinstein, Matthew E.; Karas, Maria G.; Kriss, Michael; Lim, Nicholas; Palardy, Maryse; Sawinski, Deirdre; Schonfeld, Emily; Seetharam, Anil; Sharma, Pratima; Tallaj, Jose; Dadhania, Darshana M.; VanWagner, Lisa B. (2022). "Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice- based recommendations." American Journal of Transplantation (12): 2740-2758.
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttps://hdl.handle.net/2027.42/175530
dc.publisherWiley Periodicals, Inc.
dc.subject.otherliver transplant
dc.subject.othercoronary artery disease
dc.subject.othercirrhotic cardiomyopathy
dc.subject.othercardiac outcomes
dc.titleManagement of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175530/1/ajt17049_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175530/2/ajt17049.pdf
dc.identifier.doi10.1111/ajt.17049
dc.identifier.sourceAmerican Journal of Transplantation
dc.identifier.citedreferenceJoannides R, Monteil C, de Ligny BH, et al. Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant. 2011; 11 ( 11 ): 2414 - 2422.
dc.identifier.citedreferenceKushwaha SS, Raichlin E, Sheinin Y, et al. Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J. 2008; 29 ( 22 ): 2742 - 2750.
dc.identifier.citedreferenceMurbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S. Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients–a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial. Clin Transplant. 2015; 29 ( 8 ): 678 - 684.
dc.identifier.citedreferenceSeckinger J, Sommerer C, Hinkel UP, Hoffmann O, Zeier M, Schwenger V. Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens. 2008; 26 ( 11 ): 2213 - 2219.
dc.identifier.citedreferenceRosing K, Fobker M, Kannenberg F, et al. Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. Atherosclerosis. 2013; 230 ( 1 ): 164 - 170.
dc.identifier.citedreferenceVitiello D, Neagoe PE, Sirois MG, White M. Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation. Cell Mol Immunol. 2015; 12 ( 1 ): 40 - 52.
dc.identifier.citedreferenceCharlton M, Rinella M, Patel D, McCague K, Heimbach J, Watt K. Everolimus is associated with less weight gain than tacrolimus 2 years after liver transplantation: results of a randomized multicenter study. Transplantation. 2017; 101 ( 12 ): 2873 - 2882.
dc.identifier.citedreferenceJohnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation. 2002; 73 ( 6 ): 901 - 906.
dc.identifier.citedreferenceBorg MA, van der Wouden EJ, Sluiter WJ, Slooff MJ, Haagsma EB, van den Berg AP. Vascular events after liver transplantation: a long-term follow-up study. Transpl Int. 2008; 21 ( 1 ): 74 - 80.
dc.identifier.citedreferenceUmphrey LG, Hurst RT, Eleid MF, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl. 2008; 14 ( 6 ): 886 - 892.
dc.identifier.citedreferenceEleid MF, Hurst RT, Vargas HE, Rakela J, Mulligan DC, Appleton CP. Short-term cardiac and noncardiac mortality following liver transplantation. J Transplant. 2010; 2010: 1 – 7.
dc.identifier.citedreferenceVanWagner LB, Lapin B, Levitsky J, et al. High early cardiovascular mortality after liver transplantation. Liver Transpl. 2014; 20 ( 11 ): 1306 - 1316.
dc.identifier.citedreferenceWatt KD, Fan C, Therneau T, Heimbach JK, Seaberg EC, Charlton MR. Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl. 2014; 20 ( 7 ): 791 - 797.
dc.identifier.citedreferenceJosefsson A, Fu M, Bjornsson E, Kalaitzakis E. Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis. BMC Gastroenterol. 2014; 14: 65.
dc.identifier.citedreferenceKong YG, Kang JW, Kim YK, et al. Preoperative coronary calcium score is predictive of early postoperative cardiovascular complications in liver transplant recipients. Br J Anaesth. 2015; 114 ( 3 ): 437 - 443.
dc.identifier.citedreferenceNicolau-Raducu R, Gitman M, Ganier D, et al. Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients. Liver Transpl. 2015; 21 ( 1 ): 13 - 21.
dc.identifier.citedreferenceWeick A, Chacra W, Kuchipudi A, et al. Incidence of cardiovascular and cerebrovascular events associated with sirolimus use after liver transplantation. Transplant Proc. 2015; 47 ( 2 ): 460 - 464.
dc.identifier.citedreferenceKim SH, Moon YJ, Lee S, Jeong SM, Song JG, Hwang GS. Atrioventricular conduction disturbances immediately after hepatic graft reperfusion and their outcomes in patients undergoing liver transplantation. Liver Transpl. 2016; 22 ( 7 ): 956 - 967.
dc.identifier.citedreferenceMalik MU, Russell SD, Pustavoitau A, et al. The predictors of post-transplant coronary events among liver transplant recipients. Hepatol Int. 2016; 10 ( 6 ): 974 - 982.
dc.identifier.citedreferenceScholte NTB, Lenzen MJ, van der Hoven B, Rietdijk WJR, Metselaar HJ, den Uil CA. In-hospital cardiovascular events after liver transplantation: predictors and long-term outcome. Neth Heart J. 2018; 26 ( 10 ): 506 - 511.
dc.identifier.citedreferenceSon YG, Lee H, Oh SY, Jung CW, Ryu HG. Risk factors for intensive care unit readmission after liver transplantation: a retrospective cohort study. Ann Transplant. 2018; 23: 767 - 774.
dc.identifier.citedreferenceDe Luca L, Kalafateli M, Bianchi S, et al. Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors. Liver Int. 2019; 39 ( 8 ): 1557 - 1565.
dc.identifier.citedreferenceSmilowitz NR, Guo Y, Rao S, Gelb B, Berger JS, Bangalore S. Perioperative cardiovascular outcomes of non-cardiac solid organ transplant surgery. Eur Heart J Qual Care Clin Outcomes. 2019; 5 ( 1 ): 72 - 78.
dc.identifier.citedreferenceFlaherty D, Kim S, Zerillo J, et al. Preoperative QTc interval is not associated with intraoperative cardiac events or mortality in liver transplantation patients. J Cardiothorac Vasc Anesth. 2019; 33 ( 4 ): 961 - 966.
dc.identifier.citedreferenceSiddiqui MB, Arshad T, Patel S, et al. Small dense low-density lipoprotein cholesterol predicts cardiovascular events in liver transplant recipients. Hepatology. 2019; 70 ( 1 ): 98 - 107.
dc.identifier.citedreferenceMoon YJ, Kwon HM, Jung KW, et al. Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease. Am J Transplant. 2019; 19 ( 7 ): 2053 - 2066.
dc.identifier.citedreferenceAlexander S, Teshome M, Patel H, Chan EY, Doukky R. The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates. BMC Cardiovasc Disord. 2019; 19 ( 1 ): 102.
dc.identifier.citedreferenceRachwan RJ, Kutkut I, Hathaway TJ, et al. Postoperative atrial fibrillation and flutter in liver transplantation: an important predictor of early and late morbidity and mortality. Liver Transpl. 2020; 26 ( 1 ): 34 - 44.
dc.identifier.citedreferenceHu WS, Lin CL. Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort study. Intern Emerg Med. 2019; 14 ( 1 ): 71 - 76.
dc.identifier.citedreferenceDogan U, Yaprak M, Dogan EA, Onac M, Aydinli B. Cardiac and neurologic complications in the late period after liver transplantation: a retrospective analysis of 4 years. Transplant Proc. 2019; 51 ( 4 ): 1153 - 1156.
dc.identifier.citedreferenceKoshy AN, Gow PJ, Han HC, et al. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years. Eur Heart J Qual Care Clin Outcomes. 2020; 6 ( 4 ): 243 - 253.
dc.identifier.citedreferenceNejatollahi SMR, Marashi SA, Janatmakan F, Vosoghian M, Hasanzadehkiabi M, Fazel I. A Single-center report on liver transplantation: first experiences from shahid beheshti university of medical sciences. Middle East J Dig Dis. 2020; 12 ( 4 ): 252 - 256.
dc.identifier.citedreferenceKoshy AN, Farouque O, Cailes B, et al. Prediction of perioperative cardiovascular events in liver transplantation. Transplantation. 2021; 105 ( 3 ): 593 - 601.
dc.identifier.citedreferenceCailes B, Koshy AN, Gow P, et al. Inducible left ventricular outflow tract obstruction in patients undergoing liver transplantation: prevalence, predictors, and association with cardiovascular events. Transplantation. 2021; 105 ( 2 ): 354 - 362.
dc.identifier.citedreferenceIzzy M, Soldatova A, Sun X, et al. Cirrhotic cardiomyopathy predicts post-transplant cardiovascular disease: revelations of the new diagnostic criteria. Liver Transpl. 2021; 27 ( 6 ): 876 - 886.
dc.identifier.citedreferencePark J, Lee SH, Han S, et al. An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure. Sci Rep. 2021; 11 ( 1 ): 959.
dc.identifier.citedreferenceSo WZ, Tan FL, Tan DJH, et al. A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation. Dig Liver Dis. 2021; 10.1016/j.dld.2021.11.011.
dc.identifier.citedreferencePiazza NA, Singal AK. Frequency of cardiovascular events and effect on survival in liver transplant recipients for cirrhosis due to alcoholic or nonalcoholic steatohepatitis. Exp Clin Transplant. 2016; 14 ( 1 ): 79 - 85.
dc.identifier.citedreferenceVanWagner LB, Ning H, Whitsett M, et al. A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: the CAR-OLT score. Hepatology. 2017; 66 ( 6 ): 1968 - 1979.
dc.identifier.citedreferenceWatt KD, Coss E, Pedersen RA, Dierkhising R, Heimbach JK, Charlton MR. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 2010; 16 ( 8 ): 990 - 998.
dc.identifier.citedreferenceD’Avola D, Cuervas-Mons V, Marti J, et al. Cardiovascular morbidity and mortality after liver transplantation: the protective role of mycophenolate mofetil. Liver Transpl. 2017; 23 ( 4 ): 498 - 509.
dc.identifier.citedreferenceFussner LA, Heimbach JK, Fan C, et al. Cardiovascular disease after liver transplantation: when, what, and who is at risk. Liver Transpl. 2015; 21 ( 7 ): 889 - 896.
dc.identifier.citedreferenceDurand F. How to improve long-term outcome after liver transplantation? Liver Int. 2018; 38 ( Suppl 1 ): 134 - 138.
dc.identifier.citedreferenceWong RJ, Singal AK. Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Netw Open. 2020; 3 ( 2 ): e1920294.
dc.identifier.citedreferenceHaldar D, Kern B, Hodson J, et al. Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study. J Hepatol. 2019; 71 ( 2 ): 313 - 322.
dc.identifier.citedreferenceKhurmi NS, Chang YH, Eric Steidley D, et al. Hospitalizations for cardiovascular disease after liver transplantation in the United States. Liver Transpl. 2018; 24 ( 10 ): 1398 - 1410.
dc.identifier.citedreferenceYong JN, Lim WH, Ng CH, et al. Outcomes of nonalcoholic steatohepatitis after liver transplantation: an updated meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2021. 10.1016/j.cgh.2021.11.014
dc.identifier.citedreferenceGroup OLoEW, Durieux N, Pasleau F, et al. The 2011 Oxford CEBM levels of evidence: Introductory document. Oxford Cent Evidence-Based Med. 2011; 1 ( 12 ): 1 - 3.
dc.identifier.citedreferenceVanWagner LB, Serper M, Kang R, et al. Factors associated with major adverse cardiovascular events after liver transplantation among a national sample. Am J Transplant. 2016; 16 ( 9 ): 2684 - 2694.
dc.identifier.citedreferenceXiao J, Yong JN, Ng CH, et al. A meta-analysis and systematic review on the global prevalence, risk factors, and outcomes of coronary artery disease in liver transplantation recipients. Liver Transpl. 2021; 28 ( 4 ): 689 - 699.
dc.identifier.citedreferenceTsai H-I, Liu F-C, Lee C-W, et al. Cardiovascular disease risk in patients receiving organ transplantation: a national cohort study. Transplant Int. 2017; 30 ( 11 ): 1161 - 1171.
dc.identifier.citedreferenceBarman PM, Vanwagner LB. Cardiac risk assessment in liver transplant candidates: current controversies and future directions. Hepatology. 2020; 73 ( 6 ): 2564 - 2576.
dc.identifier.citedreferenceKoshy AN, Gow PJ, Han HC, et al. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years. Eur Heart J Qual Care Clin Outcomes. 2020; 6 ( 4 ): 243 - 253.
dc.identifier.citedreferenceKwong AJ, Devuni D, Wang C, et al. Outcomes of liver transplantation among older recipients with nonalcoholic steatohepatitis in a large multicenter US cohort: the re-evaluating age limits in transplantation consortium. Liver Transpl. 2020; 26 ( 11 ): 1492 - 1503.
dc.identifier.citedreferenceGuckelberger O, Mutzke F, Glanemann M, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transpl. 2006; 12 ( 3 ): 394 - 401.
dc.identifier.citedreferenceDiedrich DA, Findlay JY, Harrison BA, Rosen CB. Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc. 2008; 40 ( 10 ): 3554 - 3557.
dc.identifier.citedreferencePatel SS, Rodriguez VA, Siddiqui MB, et al. The impact of coronary artery disease and statins on survival after liver transplantation. Liver Transplant. 2019; 25 ( 10 ): 1514 - 1523.
dc.identifier.citedreferencePatel SS, Lin F-P, Rodriguez VA, et al. The relationship between coronary artery disease and cardiovascular events early after liver transplantation. Liver Int. 2019; 39 ( 7 ): 1363 - 1371.
dc.identifier.citedreferenceMalik MU, Russell SD, Pustavoitau A, et al. The predictors of post-transplant coronary events among liver transplant recipients. Hep Intl. 2016; 10 ( 6 ): 974 - 982.
dc.identifier.citedreferenceMoon Y-J, Kwon H-M, Jung K-W, et al. Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease. Am J Transplant. 2019; 19 ( 7 ): 2053 - 2066.
dc.identifier.citedreferenceWolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014; 63 ( 4 ): 380 - 406.
dc.identifier.citedreferenceRabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg. 2002; 183 ( 5 ): 595 - 599.
dc.identifier.citedreferenceVanWagner LB, Gordon E, Adamski L, et al. Liver transplant recipient, caregiver, and provider perceptions of cardiovascular disease and related risk factors after transplant. Liver Transpl. 2021; 27 ( 5 ): 668 - 683.
dc.identifier.citedreferenceSakr AE, Fraser GE, Doctorian TP, et al. Predictors of systolic heart failure and mortality following orthotopic liver transplantation: a single-center cohort. Transpl Proc. 2019; 51 ( 6 ): 1950 - 1955.
dc.identifier.citedreferenceDowsley TF, Bayne DB, Langnas AN, et al. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation. 2012; 94 ( 6 ): 646 - 651.
dc.identifier.citedreferenceMcDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42 ( 36 ): 3599 - 3726.
dc.identifier.citedreferenceIzzy M, Soldatova A, Sun X, et al. Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria. Liver Transpl. 2021; 27 ( 6 ): 876 - 886.
dc.identifier.citedreferenceQureshi W, Mittal C, Ahmad U, et al. Clinical predictors of post-liver transplant new-onset heart failure. Liver Transpl. 2013; 19 ( 7 ): 701 - 710.
dc.identifier.citedreferenceEyvazian VA, Gordin JS, Yang EH, et al. Incidence, predictors, and outcomes of new-onset left ventricular systolic dysfunction after orthotopic liver transplantation. J Cardiac Fail. 2019; 25 ( 3 ): 166 - 172.
dc.identifier.citedreferenceLaish I, Braun M, Mor E, Sulkes J, Harif Y, Ben AZ. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011; 17 ( 1 ): 15 - 22.
dc.identifier.citedreferenceTriposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure: JACC review topic of the week. J Am Coll Cardiol. 2019; 74 ( 6 ): 804 - 813.
dc.identifier.citedreferenceXanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Failure. 2019; 7 ( 2 ): 87 - 97.
dc.identifier.citedreferenceIzzy M, VanWagner LB, Lin G, et al. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology. 2020; 71 ( 1 ): 334 - 345.
dc.identifier.citedreferenceKim HM, Kim HK, Lee JH, et al. Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: A comprehensive cardiovascular magnetic resonance and echocardiographic study. J Cardiovasc Magn Reson. 2020; 22 ( 1 ). 10.1186/s12968-020-00622-2
dc.identifier.citedreferenceBozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021; 23 ( 3 ): 352 - 380.
dc.identifier.citedreferenceYilmaz KC, Ciftci O, Akgun AN, et al. Relation of preoperative and postoperative echocardiographic parameters with rejection and mortality in liver transplant patients. Exp Clin Transplant. 2020; 18 ( 2 ): 210 - 214.
dc.identifier.citedreferenceYancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 62 ( 16 ): e147 - e239.
dc.identifier.citedreferenceReydellet L, Blasco V, Mercier MF, et al. Impact of a goal-directed therapy protocol on postoperative fluid balance in patients undergoing liver transplantation: a retrospective study. Ann Fr Anesth Reanim. 2014; 33 ( 4 ): e47 - e54.
dc.identifier.citedreferenceWriting Committee M, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128 ( 16 ): e240 - e327.
dc.identifier.citedreferenceVanWagner LB, Holl JL, Montag S, et al. Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipients. Am J Transplant. 2020; 20 ( 3 ): 797 - 807.
dc.identifier.citedreferenceVaduganathan M, Januzzi JL Jr. Preventing and treating heart failure with sodium-glucose co-transporter 2 inhibitors. Am J Cardiol. 2019; 124 ( Suppl 1 ): S20 - S27.
dc.identifier.citedreferenceKhan MS, Fonarow GC, McGuire DK, et al. Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization. Circulation. 2020; 142 ( 12 ): 1205 - 1218.
dc.identifier.citedreferenceGarber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary. Endocr Pract. 2020; 26 ( 1 ): 107 - 139.
dc.identifier.citedreferenceIzzy M, Vanwagner LB, Lee SS, Altieri M, Angirekula M, Watt KD. Understanding and managing cardiovascular outcomes in liver transplant recipients. Curr Opin Organ Transplant. 2019; 24 ( 2 ): 148 - 155.
dc.identifier.citedreferenceWriting C, Maddox TM, Januzzi JL Jr, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the american college of cardiology solution set oversight committee. J Am Coll Cardiol. 2021; 77 ( 6 ): 772 - 810.
dc.identifier.citedreferenceBargehr J, Trejo-Gutierrez JF, Rosser BG, et al. Liver transplantation in patients with atrial fibrillation. Transpl Proc. 2013; 45 ( 6 ): 2302 - 2306.
dc.identifier.citedreferenceVannucci A, Rathor R, Vachharajani N, Chapman W, Kangrga I. Atrial fibrillation in patients undergoing liver transplantation-a single-center experience. Transpl Proc. 2014; 46 ( 5 ): 1432 - 1437.
dc.identifier.citedreferenceBargehr J, Trejo-Gutierrez JF, Patel T, et al. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transplant. 2015; 21 ( 3 ): 314 - 320.
dc.identifier.citedreferenceVanWagner LB, Serper M, Kang R, et al. Factors associated with major adverse cardiovascular events after liver transplantation among a national sample. Am J Transplant. 2016; 16 ( 9 ): 2684 - 2694.
dc.identifier.citedreferenceMoon YJ, Kwon HM, Park YS, Kim SH, Hwang GS. Brief episodes of newly developed intraoperative atrial fibrillation predicts worse outcomes in adult liver transplantation. Transplant Proc. 2018; 50 ( 4 ): 1142 - 1146.
dc.identifier.citedreferenceRachwan RJ, Kutkut I, Hathaway TJ, et al. Postoperative atrial fibrillation and flutter in liver transplantation: an important predictor of early and late morbidity and mortality. Liver Transplant. 2020; 26 ( 1 ): 34 - 44.
dc.identifier.citedreferenceXia VW, Worapot A, Huang S, et al. Postoperative atrial fibrillation in liver transplantation. Am J Transplant. 2015; 15 ( 3 ): 687 - 694.
dc.identifier.citedreferencevan Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation. 2011; 124 ( 3 ): 289 - 296.
dc.identifier.citedreferenceJanuary CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64 ( 21 ): e1 - e76.
dc.identifier.citedreferenceChokesuwattanaskul R, Thongprayoon C, Bathini T, et al. Liver transplantation and atrial fibrillation: a meta-analysis. World J Hepatol. 2018; 10 ( 10 ): 761 - 771.
dc.identifier.citedreferenceJanuary CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019; 74 ( 1 ): 104 - 132.
dc.identifier.citedreferenceAndrade JG, Macle L, Nattel S, Verma A, Cairns J. Contemporary atrial fibrillation management: a comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol. 2017; 33 ( 8 ): 965 - 976.
dc.identifier.citedreferenceCheema A, Dong J, Dalal D, et al. Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation. J Cardiovasc Electrophysiol. 2006; 17 ( 10 ): 1080 - 1085.
dc.identifier.citedreferenceWilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010; 303 ( 4 ): 333 - 340.
dc.identifier.citedreferenceLip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137 ( 2 ): 263 - 272.
dc.identifier.citedreferencePisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138 ( 5 ): 1093 - 1100.
dc.identifier.citedreferencePatel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011; 365 ( 10 ): 883 - 891.
dc.identifier.citedreferenceGiugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013; 369 ( 22 ): 2093 - 2104.
dc.identifier.citedreferenceGoriacko P, Veltri KT. Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation. Eur J Haematol. 2018; 100 ( 5 ): 488 - 493.
dc.identifier.citedreferenceDalia AA, Kuo A, Vanneman M, Crowley J, Elhassan A, Lai Y. Anesthesiologists guide to the 2019 AHA/ACC/HRS focused update for the management of patients with atrial fibrillation. J Cardiothorac Vasc Anesth. 2019; 34 ( 7 ): 1925 - 1932.
dc.identifier.citedreferenceReddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation. 2013; 127 ( 6 ): 720 - 729.
dc.identifier.citedreferenceHolmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014; 64 ( 1 ): 1 - 12.
dc.identifier.citedreferenceReddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017; 70 ( 24 ): 2964 - 2975.
dc.identifier.citedreferenceAl-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Circulation. 2018; 138 ( 13 ): e210 - e271.
dc.identifier.citedreferenceKonerman MA, Price JC, Campbell CY, et al. Pre-liver transplant transthoracic echocardiogram findings and 6-month post-transplant outcomes: a case-control analysis. Ann Transplant. 2016; 21: 416 - 427.
dc.identifier.citedreferenceFukazawa K, Quinlan CA, Pretto EA Jr, Fong CT, Reyes JD, Gologorsky E. Chronic moderate aortic regurgitation in liver transplantation: prevalence, perioperative management, and short-term outcomes. J Cardiothorac Vasc Anesth. 2019; 33 ( 2 ): 584 - 587.
dc.identifier.citedreferenceWriting Committee M, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021; 77 ( 4 ): e25 - e197.
dc.identifier.citedreferenceShroff GR, Bangalore S, Bhave NM, et al. Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the american heart association. Circulation. 2021; 143 ( 25 ): e1088 - e1114.
dc.identifier.citedreferenceElbadawi A, Ugwu J, Elgendy IY, et al. Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients. Catheter Cardiovasc Interv. 2021; 97 ( 4 ): 691 - 698.
dc.identifier.citedreferenceUllah W, Sattar Y, Al-Khadra Y, et al. Clinical outcomes of renal and liver transplant patients undergoing transcatheter aortic valve replacement: analysis of national inpatient sample database. Expert Rev Cardiovasc Ther. 2021; 19 ( 4 ): 363 - 368.
dc.identifier.citedreferenceFarag M, Nikolic M, Arif R, et al. Cardiac surgery in patients with previous hepatic or renal transplantation: a pair-matched study. Ann Thorac Surg. 2017; 103 ( 5 ): 1467 - 1474.
dc.identifier.citedreferenceSaliba F, Fischer L, de Simone P, Bernhardt P, Bader G, Fung J. Association between renal dysfunction and major adverse cardiac events after liver transplantation: evidence from an international randomized trial of everolimus-based immunosuppression. Ann Transplant. 2018; 23: 751 - 757.
dc.identifier.citedreferenceHoldaas H, de Fijter JW, Cruzado JM, et al. Cardiovascular parameters to 2 years after kidney transplantation following early switch to everolimus without calcineurin inhibitor therapy: an analysis of the randomized ELEVATE study. Transplantation. 2017; 101 ( 10 ): 2612 - 2620.
dc.identifier.citedreferenceRaichlin E, Chandrasekaran K, Kremers WK, et al. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation. 2008; 86 ( 10 ): 1395 - 1400.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajt17049_am.pdf
Size:
838.5KB
Format:
PDF
View/Open
Name:
ajt17049.pdf
Size:
1.482MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.